Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials.
Castle
Philip E
PE
D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000188:drug therapy*
D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride
JAMA. 2006 Jun 21;295(23):2727-41
16754727
Lancet Oncol. 2008 May;9(5):425-34
18407790
J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88
9747868
J Natl Cancer Inst. 2009 Mar 18;101(6):384-98
19276457
Cochrane Database Syst Rev. 2000;(2):CD001318
10796771
Expert Rev Anticancer Ther. 2009 Jul;9(7):895-903
19589029
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):792-800
19258470
Lancet Oncol. 2009 Oct;10(10):975-80
19796749
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19467-72
19901334
Nat Rev Cancer. 2006 May;6(5):360-8
16633364
Lancet. 2008 Jan 5;371(9606):29-40
18177773
Lancet. 2007 Nov 10;370(9599):1609-21
17993361
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2490-5
15699322
BMJ. 2008 Sep 18;337:a1284
18801868
Lancet. 2007 Sep 8;370(9590):890-907
17826171